Reprogramming of IL-10 activity and signaling by IFN-γ1

被引:112
作者
Herrero, C
Hu, XY
Li, WP
Samuels, S
Sharif, MN
Kotenko, S
Ivashkiv, LB
机构
[1] Cornell Univ, Weill Grad Sch Med Sci, New York, NY 10021 USA
[2] Cornell Univ, Weill Grad Sch Med Sci, Grad Program Immunol, New York, NY 10021 USA
[3] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07103 USA
[4] Hosp Special Surg, Dept Med, New York, NY 10021 USA
关键词
D O I
10.4049/jimmunol.171.10.5034
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
One important mechanism of cross-regulation by opposing cytokines is inhibition of signal transduction, including inhibition of Janus kinase-STAT signaling by suppressors of cytokine signaling. We investigated whether IFN-gamma, a major activator of macrophages, inhibited the activity of IL-10, an important deactivator. Preactivation of macrophages with IFN-gamma inhibited two key anti-inflammatory functions of IL-10, the suppression of cytokine production and of MHC class II expression. Gene expression profiling showed that IFN-gamma broadly suppressed the ability of IL-10 to induce or repress gene expression. Although IFN-gamma induced expression of suppressor of cytokine signaling proteins, IL-10 signal transduction was not suppressed and IL-10 activation of Janus kinases and Stat3 was preserved. Instead, IFN-gamma switched the balance of IL-10 STAT activation from Stat3 to Stat1, with concomitant activation of inflammatory gene expression. IL-10 activation of Stat1 required the simultaneous presence of IFN-gamma. These results demonstrate that IFN-gamma operates a switch that rapidly regulates STAT activation by IL-10 and alters macrophage responses to IL-10. Dynamic regulation of the activation of different STATs by the same cytokine provides a mechanism by which cells can integrate and balance signals delivered by opposing cytokines, and extends our understanding of cross-regulation by opposing cytokines to include reprogramming of signaling and alteration of function.
引用
收藏
页码:5034 / 5041
页数:8
相关论文
共 44 条
  • [1] Avdiushko R, 2001, J LEUKOCYTE BIOL, V70, P624
  • [2] INTERLEUKIN-10 ADMINISTRATION DECREASES SURVIVAL IN MURINE RECIPIENTS OF MAJOR HISTOCOMPATIBILITY COMPLEX DISPARATE DONOR BONE-MARROW GRAFTS
    BLAZAR, BR
    TAYLOR, PA
    SMITH, S
    VALLERA, DA
    [J]. BLOOD, 1995, 85 (03) : 842 - 851
  • [3] The role of STATs in transcriptional control and their impact on cellular function
    Bromberg, J
    Darnell, JE
    [J]. ONCOGENE, 2000, 19 (21) : 2468 - 2473
  • [4] IL-10 stimulates production of platelet-activating factor by monocytes of patients with active systemic lupus erythematosus (SLE)
    Bussolati, B
    Rollino, C
    Mariano, F
    Quarello, F
    Camussi, G
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2000, 122 (03) : 471 - 476
  • [5] Mutational switch of an IL-6 response to an interferon-γ-like response
    Costa-Pereira, AP
    Tininini, S
    Strobl, B
    Alonzi, T
    Schlaak, JF
    Is'harc, H
    Gesualdo, I
    Newman, SJ
    Kerr, IM
    Poli, V
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (12) : 8043 - 8047
  • [6] Evidence for a dual mechanism for IL-10 suppression of TNF-α production that does not involve inhibition of p38 mitogen-activated protein kinase or NF-κB in primary human macrophages
    Denys, A
    Udalova, IA
    Smith, C
    Williams, LM
    Ciesielski, CJ
    Campbell, J
    Andrews, C
    Kwaitkowski, D
    Foxwell, BMJ
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 168 (10) : 4837 - 4845
  • [7] Interferons inhibit activation of STAT6 by interleukin 4 in human monocytes by inducing SOCS-1 gene expression
    Dickensheets, HL
    Venkataraman, C
    Schindler, U
    Donnelly, RP
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (19) : 10800 - 10805
  • [8] Suppressor. of cytokine signaling 1 inhibits IL-10-mediated immune responses
    Ding, YZ
    Chen, DM
    Tarcsafalvi, A
    Su, RH
    Qin, LH
    Bromberg, JS
    [J]. JOURNAL OF IMMUNOLOGY, 2003, 170 (03) : 1383 - 1391
  • [9] Targeted disruption of the mouse STAT1 results in compromised innate immunity to viral disease
    Durbin, JE
    Hackenmiller, R
    Simon, MC
    Levy, DE
    [J]. CELL, 1996, 84 (03) : 443 - 450
  • [10] FINBLOOM DS, 1995, J IMMUNOL, V155, P1079